Chicago City-wide Cardio-Oncology Rounds

Summary of Presentations (2019–Now)

2019

  • Feb 20

    • Doxorubicin toxicity: Monitoring and management with biomarkers and speckle tracking echocardiography (RUSH)

    • Immunotherapies: Cardiovascular toxicities and monitoring (UIC)

  • May 22

    • 5FU-associated Takotsubo’s cardiomyopathy (Northwestern)

    • Radiation-associated valve disease (U of Chicago)

  • Oct 17

    • Post-LVAD and heart transplant outcomes in patients with CTRCD (Loyola)

    • Management of vascular side effects of VEGF inhibitors – Severe refractory hypertension with bevacizumab (Advocate)

2020

  • Feb 20

    • Diagnostic challenge and therapeutic alternative in cardiac amyloidosis (Cook County)

    • Evaluation prior to stem cell transplant (U of Chicago)

  • June 17 (Virtual)

    • Valvular disease and heart failure in newly diagnosed breast cancer during COVID-19 (Advocate)

  • Sept 22 (Virtual)

    • Osimertinib-induced cardiotoxicity (Northshore)

    • Microvascular toxicity of BCR-Abl TKI in CML (Guest: Dr. Andreas M. Beyer)

  • Dec 10 (Virtual)

    • The Toxic Tango – TKI and ICI (OSF)

    • Overview of the clinical use of TKI’s and ICI’s (UIC with pharmacology)

2021

  • March 4

    • Radiation-induced heart disease: multi-spectra cases (RUSH)

    • Dilemmas in cardiotoxicity evaluation in early phase oncology trials (Northwestern)

  • May 27

    • Pulmonary vascular toxicity while on TKI: a rare CML case (U of Chicago)

    • Developing precise medicine with TKIs for CML (Northwestern)

  • Oct 2

    • RUSH Bi-Annual Cardio-Onc Meeting

  • Dec 15

    • Bruton TKI’s and cardiac arrhythmias (Cook County)

    • Multi-modality imaging of cardiac masses (Northshore)

2022

  • March 24

    • AL Amyloidosis and other light chain disease challenges (Loyola)

    • Malignancy post-cardiac transplantation: epidemiology, prevention, and management (Advocate)

  • May 19

    • Baseline CV disease and prostate cancer: androgen antagonists in management (RUSH)

    • Building a real-world big data cohort in cardio-oncology (Guest: Dr. Sherry-Ann Brown)

  • Sept 29

    • Complications in young adult pediatric cancer survivors (U of Chicago)

    • Cardiovascular concerns with CAR T-cell therapy: a case presentation (Northwestern)

  • Nov 6 (AHA)

    • Radiation heart disease: case-based discussion (U of Chicago)

    • Top takeaways from ESC 2022 Cardio-Oncology Guidelines (Northshore)

2023

  • March 9

    • HER2 therapy and hormonal impacts in breast cancer (UIC)

    • Social disparities in cardio-oncology outcomes (Cook County)

  • May 18

    • Checkpoint inhibitor toxicity: multi-organ dysfunction (Advocate)

    • Adverse cardiovascular effects of VEGFi (Loyola)

  • Sept 14 (Virtual)

    • Chemotherapy-associated CV toxicity and GDMT (ACE-Is, BBs, MRAs, SGLT-2) (RUSH)

    • Palliative care in cardio-oncology (Carle Health)

  • Dec 6

    • Imaging in cardio-oncology: beyond pictures (U of Chicago)

    • Mimicking ICI myocarditis: ACS and atherosclerosis (Northwestern)

2024

  • March 13

    • Diffuse large B-cell lymphoma: cardiac involvement (Loyola)

    • Cardiac AL amyloidosis: innovative treatments (Northshore)

  • May 22

    • Arrhythmias in cardio-oncology: post-RCHOP case (UIC)

    • Valvular heart disease in cancer patients (Cook County)

  • Sept 12

    • Immune checkpoint inhibitor pericardial diseases (RUSH, Guest: Dr. Javid Moslehi)

    • Exercise recommendations during and after cancer treatment (Advocate)

  • Dec 12

    • Anti-HER2 therapy in breast cancer with cardiomyopathy (Northwestern)

    • Lymphoma: at the heart of the matter (U of Chicago)

2025

  • March 6

    • Risk stratification and cardiac complications of bone marrow transplant (Endeavor Health)

    • QT and the Beast: QT interval and cancer therapeutics (Loyola)

  • May 8

    • Cardiovascular risk in cancer survivors planning pregnancy (UIC)

    • Mediastinal synovial sarcoma: intersection of cardiac and oncologic disease (Advocate Lutheran)